Tranexamic acid does not significantly lower postoperative bleeding after endoscopic sinus and nasal surgery
International Forum of Allergy & Rhinology · 2023
DOI: 10.1002/alr.23127 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Forum of Allergy & Rhinology, 2023. Verfasst von Ashoke Khanwalkar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Paranasal Sinuses, Nasal Surgical Procedures, Antifibrinolytic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Postoperative epistaxis is a known possibility following endoscopic sinonasal surgery. Tranexamic acid (TXA) has been shown to reduce intraoperative blood loss and improve the visual field. This study evaluated the clinical efficacy of TXA when given at end of surgery to reduce postoperative bleeding.
Methods
This randomized, double‐blinded placebo‐controlled trial was conducted from April to November 2021. Patients scheduled to undergo endoscopic sinus or nasal surgery were randomized to receive an intravenous dose of 1 g TXA or saline intraoperatively prior to extubation. A 10‐in. visual analog scale (VAS) was used to query patients regarding postoperative bleeding each day for 1 week. The medical record was examined to determine the need for additional evaluations or interventions for epistaxis.
Results
Forty patients completed the study. The mean ± SD postoperative bleeding VAS for the TXA group on the day of surgery was not significantly different from the saline group (4.82 ± 2.18 in. vs. 5.03 ± 2.14 in., p = 0.8). There were no significant differences between treatment arms on any postoperative day through day 7 (0.67 ± 1.84 in. vs. 0.87 ± 0.99 in., p = 0.7), nor in the reduction in VAS compared to the respective baseline on the day of surgery. There were no significant differences in terms of additional interventions (e.g., additional evaluation in recovery, ED, or clinic, need for packing, or return to the operating room [OR]).
Conclusion
Although TXA has previously demonstrated efficacy to reduce intraoperative bleeding during sinonasal surgery, when postoperative bleeding is already minimal at baseline, TXA does not appear to reduce it significantly further.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA.
- Department of Otolaryngology, Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Ashoke Khanwalkar, Jayakar V Nayak, Zara M Patel
Zitieren
APA
Khanwalkar, A., Chan, E., Roozdar, P., Kim, D., Ma, Y., Hwang, P. H., Nayak, J. V., & Patel, Z. M. (2023). Tranexamic acid does not significantly lower postoperative bleeding after endoscopic sinus and nasal surgery. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23127
Vancouver
Khanwalkar A, Chan E, Roozdar P, Kim D, Ma Y, Hwang PH, et al. Tranexamic acid does not significantly lower postoperative bleeding after endoscopic sinus and nasal surgery. International Forum of Allergy & Rhinology. 2023. doi:10.1002/alr.23127
BibTeX
@article{Khanwalkar2023,
author = {Khanwalkar, Ashoke and Chan, Erik and Roozdar, Pooya and Kim, Dayoung and Ma, Yifei and Hwang, Peter H and Nayak, Jayakar V and Patel, Zara M},
title = {Tranexamic acid does not significantly lower postoperative bleeding after endoscopic sinus and nasal surgery},
journal = {International Forum of Allergy & Rhinology},
year = {2023},
doi = {10.1002/alr.23127}
}
EUVIMED